LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.79
+0.68%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.04
- Revenue estimate
- $1.6M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.06
- EPS estimate
- -$0.06
- Revenue actual
- $1.5M
- Revenue estimate
- $1.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -38.8%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $6.00
- PT range
- $2.50 – $9.50
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.06 | -$0.06 | Miss -5.88% | $1.5M |
| May 14, 2026 | -$0.05 | -$0.07 | Miss -40.00% | $1.3M |
| Mar 26, 2026 | -$0.07 | -$0.10 | Miss -42.86% | $1.5M |
| Nov 12, 2025 | -$0.06 | -$0.10 | Miss -66.67% | $1.2M |
| Aug 13, 2025 | -$0.09 | -$0.10 | Miss -11.11% | $1.2M |
| May 14, 2025 | -$0.09 | -$0.16 | Miss -77.78% | $828.0K |
| Mar 24, 2025 | -$0.15 | -$0.19 | Miss -26.67% | $1.2M |
| Nov 13, 2023 | -$0.27 | -$0.24 | Beat 11.11% | $783.0K |
| Aug 14, 2023 | -$0.32 | -$0.23 | Beat 28.13% | $159.0K |
| May 15, 2023 | -$0.35 | -$0.24 | Beat 31.43% | $446.0K |
| Mar 14, 2023 | $0.38 | -$0.29 | Miss -176.32% | $112.0K |
| Nov 14, 2022 | -$0.40 | -$0.28 | Beat 30.00% | $76.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026